Pharma Journalist 9027 posts 0 comments

EMA has reviewed the latest evidence on the use of ivermectin for the prevention and treatment of COVID-19 and concluded that the available data do not support its use for COVID-19…
Read More...

Komodo Health announced a $220 million Series E funding round led by Tiger Global Management and joined by Casdin Capital. Existing investors ICONIQ Growth, Andreessen Horowitz, and SVB…
Read More...

The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy at preventing severe…
Read More...

Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in…
Read More...

Indivumed GmbH announced the founding of Ix Therapeutics GmbH, a joint venture with Xlife Sciences AG, which marks Indivumed's expansion into target discovery and early cancer drug…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY (ponesimod), a once-daily oral selective…
Read More...

Oramed Pharmaceuticals Inc. a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that it has entered into definitive agreements to…
Read More...

SMi Group Reports: Chair of the conference, Justin Mason-Home, personal invitation to join the 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference, on 10-11 May 2021…
Read More...

Pyxis Oncology announced that it has entered into a worldwide license agreement with Pfizer Inc. for the development and commercialization of two antibody-drug conjugate (ADC)…
Read More...

Boston Pharmaceuticals announced a pioneering three-year out-license and option agreement with GlaxoSmithKline PLC. Boston Pharmaceuticals will become a preferred GSK partner for select…
Read More...